[ad_1]
Mankind Pharma IPO: If you want to invest in Mankind Pharma IPO, then this is your last chance. Investors can subscribe to it only till Thursday, April 27, 2023. According to the report published in Economic Times, till the third and last day of opening of the IPO, the quota of Non-Institutional Investors (NIIs) has been subscribed up to 1.34 times. On the other hand, if we talk about the reserve quota for institutional investors (QIB), it has been subscribed up to 5.68 times. At the same time, till now retail investors have not shown much interest in this IPO, their quota has been subscribed only up to 35 percent. In this case, this IPO has been subscribed up to a total of 2.08 times.
Know the special features of IPO-
- Mankind Pharma’s IPO is completely based on Offer for Sale.
- The company is trying to raise a total of Rs 4326.36 crore through this IPO.
- The price band of this IPO has been fixed from Rs 1024 to Rs 1080.
- In an IPO, investors can apply for a lot of 13 shares at a time.
- Talking about the premium of the IPO, it is expected to pay a premium of Rs 65 in the unlisted market. Earlier till yesterday, it was expected that it would give a premium of up to Rs.90.
- Mankind Pharma has issued 1.2 crore shares worth Rs 1,297 crore to 77 anchor investors.
- Many foreign institutions like Goldman Sachs, Government of Singapore, Canada Pension Plan, Fidelity Investment Trust etc. have invested in the anchor round.
- In this IPO, the company has reserved a quota of 50 per cent for qualified institutional buyers, 15 per cent for HNIs and 35 per cent for retail investors.
Learn the details of Mankind Pharma Company-
Mankind Pharma is a large pharma company in the country which manufactures condoms and pregnancy kits under brand names like Prega News and Manforce condoms. It is the fourth largest pharma company in India. It has more than 25 manufacturing units across the country. On the other hand, talking about the company’s earnings, in the financial year 2022, it had increased from 6,385.38 crores to 7,977.58 crores. In such a situation, a year-on-year increase of 24.94 percent has been registered in the sale.
When will be the listing of shares
Mankind Pharma’s shares will be listed on both the Bombay Stock Exchange and the National Stock Exchange. The company is trying to raise a total of Rs 4326.36 crore through this IPO. The opening of this IPO took place on 25 April 2023, which will end today i.e. 27 April 2023. The listing of the shares will take place on May 9, 2022.
read this also-
MSSC Scheme: Smriti Irani also had to line up for this post office scheme
[ad_2]
Source link